Intravenous ferric derisomaltose for iron-deficiency anemia associated with gastrointestinal diseases: a single-arm, randomized, uncontrolled, open-label study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-3774
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Intravenous ferric derisomaltose for iron-deficiency anemia associated with gastrointestinal diseases: a single-arm, randomized, uncontrolled, open-label study ; day:22 ; month:7 ; year:2022 ; pages:1-10
International journal of hematology ; (22.7.2022), 1-10
- Urheber
-
Kawabata, Hiroshi
Tamura, Takeshi
Tamai, Soichiro
Takahashi, Tomoki
Kato, Jun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12185-022-03420-x
- URN
-
urn:nbn:de:101:1-2022100321414477926389
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.05.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kawabata, Hiroshi
- Tamura, Takeshi
- Tamai, Soichiro
- Takahashi, Tomoki
- Kato, Jun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
Correction to: Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
Individualized anemia management enhanced by ferric pyrophosphate citrate protocol
A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China
Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia
Treatment of anemia of inflammation with intravenous ferric carboxymaltose in a murine anemia model using heat-killed brucella abortus
Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia
Safety, pharmacokinetics, and pharmacodynamics of intravenous ferric carboxymaltose in children with iron deficiency anemia
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
Efficacy of oral ferric citrate hydrate treatment for anemia caused by niraparib: a case report
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial
Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
Correction to: Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
Individualized anemia management enhanced by ferric pyrophosphate citrate protocol
A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China
Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia
Treatment of anemia of inflammation with intravenous ferric carboxymaltose in a murine anemia model using heat-killed brucella abortus
Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia
Safety, pharmacokinetics, and pharmacodynamics of intravenous ferric carboxymaltose in children with iron deficiency anemia
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
Efficacy of oral ferric citrate hydrate treatment for anemia caused by niraparib: a case report
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
Gene replacement therapy in Bietti crystalline corneoretinal dystrophy: an open-label, single-arm, exploratory trial
Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
Correction to: Intravenous ferric derisomaltose versus saccharated ferric oxide for iron deficiency anemia associated with menorrhagia: a randomized, open-label, active-controlled, noninferiority study
Individualized anemia management enhanced by ferric pyrophosphate citrate protocol
A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China
Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia
Treatment of anemia of inflammation with intravenous ferric carboxymaltose in a murine anemia model using heat-killed brucella abortus
Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia
Safety, pharmacokinetics, and pharmacodynamics of intravenous ferric carboxymaltose in children with iron deficiency anemia
Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
Efficacy of oral ferric citrate hydrate treatment for anemia caused by niraparib: a case report
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial